Stocks to Watch: Seer, Orthofix Medical, Halozyme Therapeutics
Dow Jones07-03 06:57
Seer Chief Executive Officer and Chair Omid Farokhzad offered to buy the company for $2.45 a share in cash, plus two contingent value rights. Shares surged 39%, to $2.25, after the bell on Thursday.
Orthofix Medical said Medicare reimbursement rates are being restored to original levels following a reversal from the Centers for Medicare & Medicaid Services. The stock gained 7.9%, to $10.72, in after-hours trading.
Halozyme Therapeutics said its chief operating officer was leaving the company. Shares fell 3.1%, to $77.00.
Write to Elias Schisgall at elias.schisgall@wsj.com
(END) Dow Jones Newswires
July 02, 2026 18:57 ET (22:57 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments